Ignatia Amara

Strychnos Ignatii Seed is a botanical extract primarily classified as a Non-Standardized Food Allergenic Extract. It contains potent alkaloids such as strychnine and brucine, which act as central nervous system stimulants and are utilized in specialized allergenic testing and pharmacological research.

Dosage for Strychnos Ignatii Seed is highly individualized and depends entirely on the clinical application (e.g., allergenic testing vs. therapeutic use).

• Allergenic Testing: Typically administered as a single drop of a 1:10 or 1:100 w/v dilution for skin prick tests.
• Therapeutic Use: In standardized preparations, doses are often micro-gram based to avoid toxicity.

Strychnos Ignatii Seed is generally not approved for pediatric use in its stimulant or concentrated form due to the high risk of alkaloid poisoning. Use in children is restricted to highly regulated allergenic testing performed by a board-certified allergist.

Renal Impairment

Patients with reduced kidney function (CrCl < 30 mL/min) may require lower doses or longer intervals between tests due to decreased clearance of strychnine-related alkaloids.

Hepatic Impairment

Because the liver is the primary site of detoxification for the seed's alkaloids, patients with hepatic cirrhosis or acute hepatitis should avoid systemic exposure.

Elderly Patients

Older adults are more susceptible to the adrenergic effects (increased heart rate/blood pressure) and should be monitored closely during administration.

For allergenic extracts, the substance is applied to the skin by a healthcare professional. If using a prescribed oral preparation:

• Take exactly as directed on the prescription label.
• Do not crush or chew seeds if provided in raw form (though raw form is rarely prescribed).
• Store in a cool, dry place away from children, as accidental ingestion can be fatal.

If a dose is missed, take it as soon as remembered unless it is nearly time for the next dose. Do not double the dose to catch up.

Strychnine poisoning is a medical emergency. Signs of overdose include:

• Severe muscle spasms or "stiffening" of the body.
• Extreme sensitivity to light and sound.
• Difficulty breathing (respiratory paralysis).
• Seizures.

In case of suspected overdose, call 911 or your local emergency services immediately.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.

When used as an allergenic extract, the most common reactions are localized:

• Injection Site Redness: A small red bump or "wheal" at the site of testing.
• Itching: Localized pruritus that typically subsides within 24 hours.
• Mild Restlessness: A slight feeling of jitteriness due to the stimulant properties.

• Increased Heart Rate: Palpitations or a racing heart.

Strychnos Ignatii Seed contains strychnine, one of the most toxic substances known. It must only be used under the direct supervision of a qualified medical professional.

No FDA black box warnings for Strychnos Ignatii Seed in its allergenic extract form; however, strict adherence to dilution protocols is required to prevent systemic toxicity.

• Allergic Reactions: As an allergenic extract, there is a risk of inducing a systemic allergic reaction (anaphylaxis) during testing. Testing should only occur in facilities equipped with epinephrine and resuscitation equipment.
• Neurotoxicity: Patients with pre-existing seizure disorders or neurological conditions (e.g., Epilepsy, Multiple Sclerosis) are at higher risk for adverse CNS effects.

• Other CNS Stimulants (e.g., Amphetamines, Cocaine): Concurrent use can lead to life-threatening hypertension, tachycardia, and seizures.
• MAO Inhibitors (e.g., Phenelzine, Selegiline): May cause a hypertensive crisis due to synergistic effects on catecholamines.

• Antipsychotics (e.g., Haloperidol): Strychnine alkaloids can lower the seizure threshold, counteracting the effects of some neuroleptics.
• Beta-Blockers: May lead to unopposed alpha-adrenergic activity, causing paradoxical hypertension.

• Hypersensitivity: Any known allergy to Strychnos species or related botanical extracts.
• Pregnancy: Due to the potent neurotoxic and uterine stimulant effects of strychnine.
• Seizure Disorders: Conditions like epilepsy are an absolute contraindication due to the glycine-antagonistic effects of the seed.
• Severe Hypertension: Uncontrolled high blood pressure.

• Anxiety Disorders

FDA Category X (Estimated). Strychnos Ignatii Seed is contraindicated in pregnancy. The alkaloids strychnine and brucine can cross the placenta and are known to be teratogenic in animal studies. Furthermore, it may act as an abortifacient by inducing uterine contractions.

It is unknown if the components of Strychnos Ignatii Seed pass into breast milk. However, due to the extreme toxicity of the alkaloids to the developing infant nervous system, breastfeeding is not recommended while using this substance.

Safety and effectiveness in pediatric populations have not been established. Use is restricted to diagnostic allergenic testing by specialists. Accidental ingestion in children is often fatal.

Strychnos Ignatii Seed acts primarily as a Glycine Receptor Antagonist. By blocking the inhibitory neurotransmitter glycine in the spinal cord, it allows for unchecked excitatory neurotransmission. Additionally, it functions as an Adrenergic Agonist, stimulating alpha and beta receptors, and exhibits Ammonium Ion Binding Activity, which may play a role in its metabolic profile.

The onset of action for CNS stimulation is approximately 15–30 minutes after oral ingestion. The duration of effect lasts between 6 and 12 hours. Tolerance to the stimulant effects can develop with repeated use, though the toxic threshold remains constant, increasing the risk of poisoning.

| Parameter | Value |

|---|---|